Multi- and polypharmacology of carbonic anhydrase inhibitors

碳酸酐酶 药理学 乙酰唑胺 化学 生物化学 医学 酶 内科学
作者
Claudiu Trandafir Supuran
出处
期刊:Pharmacological Reviews [American Society for Pharmacology and Experimental Therapeutics]
卷期号:77 (1): 100004-100004 被引量:90
标识
DOI:10.1124/pharmrev.124.001125
摘要

Eight genetically distinct families of the enzyme carbonic anhydrase (CA, EC 4.2.1.1) have been described in organisms overall in the phylogenetic tree. They catalyze the hydration of CO2 to bicarbonate and protons and are involved in pH regulation, chemosensing, and metabolism. The 15 α-CA isoforms present in humans are pharmacological drug targets known for decades, their inhibitors being used as diuretics, antiglaucoma, antiepileptic, or antiobesity drugs, as well as for the management of acute mountain sickness, idiopathic intracranial hypertension, and recently, as antitumor theragnostic agents. Other potential applications include the use of CA inhibitors (CAIs) in inflammatory conditions, cerebral ischemia, neuropathic pain, or Alzheimer/Parkinson disease management. CAs from pathogenic bacteria, fungi, protozoans, and nematodes have started to be considered as drug targets in recent years, with notable advances being registered. CAIs have a complex multipharmacology probably unique to this enzyme, which has been exploited intensely but may lead to other relevant applications in the future due to the emergence of drug design approaches that afforded highly isoform-selective compounds for most α-CAs known to date. They belong to a multitude of chemical classes (sulfonamides and isosteres, [iso]coumarins and related compounds, mono- and dithiocarbamates, selenols, ninhydrines, boronic acids, benzoxaboroles, etc). The polypharmacology of CAIs will also be discussed because drugs originally discovered for the treatment of non-CA related conditions (topiramate, zonisamide, celecoxib, pazopanib, thiazide, and high-ceiling diuretics) show effective inhibition against many CAs, which led to their repurposing for diverse pharmacological applications. SIGNIFICANCE STATEMENT: CAIs have multiple pharmacologic applications, such as diuretics, antiglaucoma, antiepileptic, antiobesity, antiacute mountain sickness, anti-idiopathic intracranial hypertension, and antitumor drugs. Their use in inflammatory conditions, cerebral ischemia, neuropathic pain, or neurodegenerations has started to be investigated recently. Parasite carbonic anhydrases are also drug targets for anti-infectives with novel mechanisms of action that can bypass drug resistance to commonly used agents. Drugs discovered for the management of other conditions that effectively inhibit these enzymes exert interesting polypharmacologic effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
水沐菁华发布了新的文献求助10
1秒前
诚心的琦完成签到,获得积分10
1秒前
1秒前
俭朴南风发布了新的文献求助10
1秒前
2秒前
2秒前
gsokok完成签到,获得积分10
4秒前
盒子发布了新的文献求助10
4秒前
王亚娟发布了新的文献求助10
5秒前
JamesPei的应助被lxlx111采纳,获得10
5秒前
科研通AI6.4的应助被lanchuan采纳,获得10
5秒前
6秒前
CodeCraft的应助被时思采纳,获得10
6秒前
宇明完成签到,获得积分10
6秒前
Huaaaaay发布了新的文献求助10
7秒前
十四完成签到,获得积分10
7秒前
7秒前
Paranoieam完成签到,获得积分10
7秒前
7秒前
ESTHERDY完成签到,获得积分10
8秒前
10秒前
xzlijingjing完成签到 ,获得积分10
10秒前
王亚娟完成签到,获得积分10
10秒前
乐乐的应助被苏小咩采纳,获得10
10秒前
11秒前
宇明发布了新的文献求助10
11秒前
催化剂完成签到,获得积分10
11秒前
ESTHERDY发布了新的文献求助20
12秒前
kkkkkkk完成签到 ,获得积分10
12秒前
勒言发布了新的文献求助10
12秒前
啊啊啊啊完成签到 ,获得积分10
13秒前
14秒前
卿云完成签到 ,获得积分10
15秒前
15秒前
华仔的应助被勒言采纳,获得10
16秒前
16秒前
赘婿的应助被王禹垚采纳,获得10
17秒前
rururu发布了新的文献求助10
17秒前
18秒前
上官若男的应助被lyj采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239